Table V.
Drug | PK Parameters | Pregnant Women (third trimester) | Non-pregnant Women (PP) | Fold Change (pregnant vs. non-pregnant) | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Observeda | Predictedb | Prediction Fold errorc | Observeda | Predictedb | Prediction Fold errorc | Observeda | Predictedb | Prediction Fold errorc | ||
Metformin | C max_ss (ng/mL) | 1,135 | 1,068, 1,070 | 1.0, 1.1 | 1,611 | 1,471 | 1.1 | 0.71 | 0.73, 0.73 | 1.0, 1.0 |
t max (h) | 2.0 | 2.5, 2.6 | 1.2, 1.3 | 1.8 | 2.4 | 1.4 | ||||
AUC12h_ss (ng h/mL) | 6,937 | 6,563, 6,698 | 1.0, 1.0 | 9,804 | 9,463 | 1.0 | 0.70 | 0.69, 0.71 | 1.0, 1.0 | |
Digoxin | C max (ng/mL) | 0.8 | 0.84, 0.81 | 1.1, 1.0 | 1.1 | 1.01 | 1.1 | 0.90 | 0.83, 0.80 | 1.1, 1.1 |
t max (h) | 1.6 | 1.7, 1.6 | 1.1, 1.0 | 1.3 | 1.6 | 1.2 | ||||
AUC48h (ng h/mL) | 7.3 | 8.0, 8.1 | 1.1, 1.1 | 9.3 | 9.54 | 1.0 | 0.81 | 0.84, 0.85 | 1.0, 1.0 | |
Midazolam | C max (ng/mL) | 6.4 | 5.33, 5.11 | 1.2, 1.3 | 9.3 | 9.5 | 1.1 | 0.72 | 0.56, 0.54 | 1.3, 1.3 |
t max (h) | 0.56 | 0.4, 0.4 | 1.4, 1.4 | 0.54 | 0.4 | 1.4 | ||||
AUCinf (ng h/mL) | 9.5 | 12.5, 12.2 | 1.3, 1.3 | 17.9 | 22.7 | 1.1 | 0.54 | 0.55, 0.54 | 1.0, 1.0 | |
Emtricitabine | C max_ss (μg/mL) | 1.4 | 0.94, 0.96 | 1.5, 1.5 | 1.4 | 1.3 | 1.2 | 0.97 | 0.72, 0.74 | 1.3, 1.3 |
t max (h) | 2.0 | 1.4, 1.5 | 1.4, 1.3 | 2.0 | 1.3 | 1.4 | ||||
AUC24h_ss (μg h/mL) | 8.0 | 8.0, 8.0 | 1.0, 1.0 | 9.7 | 11.2 | 1.1 | 0.82 | 0.71, 0.71 | 1.2, 1.2 |
aObserved data was obtained from values reported in the literatures
bPredicted PK parameters are presented as “model 1, model 2”
cFold error (FE) was calculated as FE = 10|log(Predicted/Observed)|. Calculated FE are presented as “model 1, model 2”